|
|
Advertisement |
 |
|
|
|
Advertisement |
 |
|
|
Advertisement |
 |
Deloitte's 2018 Life Sciences Accounting & Financial Reporting Update
How can life sciences companies keep pace with emerging accounting and financial reporting challenges? Learn about new accounting standards for revenue recognition, leases, and definition of a business and existing rules for R&D, acquisitions and divestitures, income taxes and more. Our ninth annual report also includes interpretive guidance to help you address these challenges.
Download now
|
|
Advertisement |
Generation Z is bringing a new pool of qualified and skilled candidates to the pharmaceutical industry. How will you ensure they engage and grow with your company? With a full-service loyalty provider, implementing an employee engagement program is simple. Work with a partner that can design and implement an effective program, one that understands the desires and motivation of Gen Z.
Work with Rymax
|
|
|
|
/ June 13–14: Connected Devices in Life Sciences / |
Boston, MA |
/ June 14: GTN Bootcamp for Bioscience Companies / |
San Francisco, CA |
/ June 19–20: Rare Disease Innovation Summit
/ |
Boston, MA |
/ June 21–22: Disruptive Downstream Technologies / |
San Diego, CA |
/ August 14–15: Publication Planning 2018 / |
Philadelphia, PA |
/ August 15–16: Reimbursement and Access 2018 / |
Philadelphia, PA |
/ August 20–22: Transparency and Aggregate Spend 2018 / |
Washington, DA, PA |
/ October 15–17: 28th Annual Sharing Conference: Compliance / |
National Harbor, MD |
/ November 13–14: Commercial Data Insights 2018 / |
Philadelphia, PA |
/ November 13–14: Due Diligence for Life Sciences M&A, Partnerships and Divestitures / |
Philadelphia, PA |
/ November 14–15: Compliant Patient Support Programs Summit / |
Chicago, IL |
/ November 14–15: 5th Annual Global Compliance Congress for Life Sciences
/ |
London, UK |
/ November 15–16: Bio/Pharma Compliance Congress on Non-Promotional Activities / |
Philadelphia, PA |
/ December 4–5: Managed Markets Compliance Congress
2018
/ |
Philadelphia, PA |
|
|
|
Advertisement |
Do you know an Emerging Pharma Leader?
Nominate a colleague with impressive leadership and career intentions — even yourself! — for Pharmaceutical Executive's 2018 Emerging Pharma Leaders Awards.
Submit your nomination today!
|
|
Advertisement |
The world is larger than you think - Don't get lost
Cultural insight the key to doing business in a globalized world. Become a global business insider with Pharma Reports, a series of PDF-format reports detailing the latest market conditions and opportunities in more than 10 countries.
Explore now
|
|
|
Industry update |
//
Astellas announced that Bernhardt G. Zeiher, M.D., F.C.C.P., F.A.C.P. was promoted to Chief Medical Officer. Zeiher will continue serving as President of Development, while also overseeing all other functions of Astellas' Medical and Development organization.
//
Immatics (Houston, TX) announced the appointment of Stephen Eck, M.D., Ph.D. as Chief Medical Officer.//
ORIC Pharmaceuticals (San Francisco, CA) appointed Jacob Chacko, M.D. as Chief Executive Officer. Rich Heyman, Ph.D., who has been serving as the interim CEO, will become Chairman of the ORIC Board of Directors. The current Chairman, Peter Svennilson, will remain on the board.
//
Nurix (San Francisco, CA) appointed Dr. Nancy Pryer as Chief Development Officer.
//
Stephanie Noviello, M.D., M.P.H. joined Motif Bio (New York, BY) as Vice President, Clinical Development.//
AMAG Pharmaceuticals (Waltham, MA) appointed J. Alan Butcher as Executive Vice President and Chief Business Officer.
//
|
|
|
Advertisement |
Don't let your campaign fall apart
Strategic product management is the glue holding an operation together. This Pharmaceutical Executive handbook is your go-to guide for effective and profitable product management.
Read more
|
|
Advertisement |
Patient Engagement in Clinical Trials
Thursday, May 17, 2018 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
Register now
|
|
Advertisement |
Capturing The Attention of Investors: How to create a compelling value story
On Demand
Learn more
|
|
Q&A |
 |
Ann Aerts, Novartis Foundation |
Dr. Ann Aerts talks to Pharm Exec about the Novartis Foundation initiatives to help with cardiovascular complications, hypertension, and other diseases in low- and middle-income countries
… /Read more/ |
|
|
|
|